Literature DB >> 2635738

Hepatic modeling of metabolite kinetics in sequential and parallel pathways: salicylamide and gentisamide metabolism in perfused rat liver.

X Xu1, K S Pang.   

Abstract

Previous data on salicylamide (SAM) metabolism in the perfused rat liver had indicated that SAM was metabolized by three parallel (competing) pathways: sulfation, glucuronidation, and hydroxylation, whereas sequential metabolism of the hydroxylated metabolite, gentisamide (GAM), was solely via 5-glucuronidation to form GAM-5G. However, under comparable conditions, preformed GAM formed mainly two monosulfate conjugates at the 2- and 5-positions (GAM-2S and GAM-5S); 5-glucuronidation was a minor pathway. In the present study, the techniques of normal (N) and retrograde (R) rat liver perfusion with SAM and mathematic modeling on SAM and GAM metabolism were used to explore the role of enzymic distributions in determining the dissimilar fates of GAM, as a generated metabolite of SAM or as preformed GAM. Changes in the steady-state extraction ratio of SAM (E) and metabolite formation ratios between N and R perfusions were used as indices of the uneven distribution of enzyme activities. Two SAM concentrations (134 and 295 microM) were used for single-pass perfusion: the lower SAM concentration exceeded the apparent Km for SAM sulfation but was less than those for SAM glucuronidation and hydroxylation; the higher concentration exceeded the apparent Km's for SAM sulfation and glucuronidation but was less than the Km for hydroxylations. Simulation of SAM metabolism data was carried out with various enzyme distribution patterns and extended to include GAM metabolism. At both input concentrations, E was high (0.94 at 134 microM and 0.7 at 295 microM) and unchanged during N and R, with SAM-sulfate (SAM-S) as the major metabolite and GAM-5G as the only detectable metabolite of GAM. Saturation of SAM sulfation occurred at the higher input SAM concentration as shown by a decrease in E and a proportionally less increase in sulfation rates and proportionally more than expected increases in SAM hydroxylation and glucuronidation rates. At both SAM concentrations, the steady-state ratio of metabolite formation rates for SAM-S/SAM-G decreased when flow direction changed from N to R. An insignificant decrease in SAM-S/SAM-OH was observed at the low input SAM concentration, due to the small amount of SAM-OH formed and hence large variation in the ratio among the preparations, whereas at the high input SAM concentration, the decrease in SAM-S/SAM-OH with a change in flow direction from N to R was evident. The metabolite formation ratio, SAM-G/SAM-OH, however, was unchanged at both input concentrations and flow directions.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2635738     DOI: 10.1007/bf01062123

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  27 in total

1.  Competing pathways in drug metabolism. I. Effect of input concentration on the conjugation of gentisamide in the once-through in situ perfused rat liver preparation.

Authors:  M E Morris; V Yuen; B K Tang; K S Pang
Journal:  J Pharmacol Exp Ther       Date:  1988-05       Impact factor: 4.030

Review 2.  Structural aspects of the membrane of the endoplasmic reticulum.

Authors:  J W Depierre; G Dallner
Journal:  Biochim Biophys Acta       Date:  1975-12-29

3.  Glucuronidation of 7-hydroxycoumarin in periportal and pericentral regions of the lobule in livers from untreated and 3-methylcholanthrene-treated rats.

Authors:  J G Conway; F C Kauffman; T Tsukuda; R G Thurman
Journal:  Mol Pharmacol       Date:  1988-01       Impact factor: 4.436

4.  Distribution of UDPglucuronosyltransferase in rat tissue.

Authors:  J R Chowdhury; P M Novikoff; N R Chowdhury; A B Novikoff
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

5.  Rates of sulfation and glucuronidation of 7-hydroxycoumarin in periportal and pericentral regions of the liver lobule.

Authors:  J G Conway; F C Kauffman; S Ji; R G Thurman
Journal:  Mol Pharmacol       Date:  1982-09       Impact factor: 4.436

6.  An enzyme-distributed system for lidocaine metabolism in the perfused rat liver preparation.

Authors:  K S Pang; J A Terrell; S D Nelson; K F Feuer; M J Clements; L Endrenyi
Journal:  J Pharmacokinet Biopharm       Date:  1986-04

7.  Combined hepatic arterial-portal venous and hepatic arterial-hepatic venous perfusions to probe the abundance of drug metabolizing activities: perihepatic venous O-deethylation activity for phenacetin and periportal sulfation activity for acetaminophen in the once-through rat liver preparation.

Authors:  K S Pang; W F Cherry; J Accaputo; A J Schwab; C A Goresky
Journal:  J Pharmacol Exp Ther       Date:  1988-11       Impact factor: 4.030

8.  Sulfoconjugation and glucuronidation of salicylamide in isolated rat hepatocytes.

Authors:  M Koike; K Sugeno; M Hirata
Journal:  J Pharm Sci       Date:  1981-03       Impact factor: 3.534

9.  Reducing equivalents for mixed function oxidation in periportal and pericentral regions of the liver lobule in perfused livers from normal and phenobarbital-treated rats.

Authors:  S A Belinsky; F C Kauffman; R G Thurman
Journal:  Mol Pharmacol       Date:  1984-11       Impact factor: 4.436

10.  Metabolism of acetaminophen and phenacetin by isolated rat hepatocytes. A system in which the spatial organization inherent in the liver is disrupted.

Authors:  K S Pang; P Kong; J A Terrell; R E Billings
Journal:  Drug Metab Dispos       Date:  1985 Jan-Feb       Impact factor: 3.922

View more
  3 in total

Review 1.  Physiologically-based pharmacokinetic modeling for absorption, transport, metabolism and excretion.

Authors:  K Sandy Pang; Matthew R Durk
Journal:  J Pharmacokinet Pharmacodyn       Date:  2010-12-14       Impact factor: 2.745

2.  A comparative investigation of hepatic clearance models: predictions of metabolite formation and elimination.

Authors:  M V St-Pierre; P I Lee; K S Pang
Journal:  J Pharmacokinet Biopharm       Date:  1992-04

3.  Nonlinear protein binding and enzyme heterogeneity: effects on hepatic drug removal.

Authors:  X Xu; P Selick; K S Pang
Journal:  J Pharmacokinet Biopharm       Date:  1993-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.